LeMaitre Vascular (NASDAQ: LMAT) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ...

Medtronic announced that the FDA has approved new labeling for the company’s Endurant stent graft system for use in the t ...

Clearance expands Company's competitive advantage of clinically proven, minimally invasive technologies to treat debilitating SI joint conditions from multiple surgical approaches~~SImmetry+'s New 3D ...

Scientists have discovered a method to induce human endothelial cells from a small biopsy sample to multiply in the laboratory, producing more than enough cells to replace damaged blood vessels or ...

The advancements of minimally invasive cardiac surgery for seniors often give them a better chance for a speedy recovery, as ...

Endovascular aneurysm repair is a minimally invasive technique for the treatment of abdominal aortic aneurysms—life-threatening bulges in the aorta's ...

Shape Memory Medical Inc. announced that it has reached 50% enrollment in the ongoing AAA-SHAPE Pivotal Trial (NCT06029660) eva ...

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, ...

Endovascular aneurysm repair is a minimally invasive technique for the treatment of abdominal aortic ...

Wall Street feels these five Dividend Aristocrat stocks are the best values in the group and offer the best entry points for investors seeking dependable income with growth potential.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.